We are live on ! Find out more
AIM

Alerce Investment Management Portfolio holdings

AUM $56.8M
1-Year Est. Return 31.17%
This Fund
S&P 500
This Quarter Est. Return
+40.05%
1 Year Est. Return
+31.17%
3 Year Est. Return
+25.12%
5 Year Est. Return
10 Year Est. Return
AUM
$104M
AUM Growth
+$50M
Cap. Flow
+$41.5M
Cap. Flow %
40%
Top 10 Hldgs %
100%
Holding
7
New
Increased
4
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANNX icon
1
Annexon
ANNX
$834M
$27.2M 26.24%
4,408,966
+2,453,988
+126% +$13.3M
AMWL icon
2
American Well
AMWL
$180M
$25.5M 24.55%
355,039
+40,000
+13% +$3.5M
GBT
3
DELISTED
Global Blood Therapeutics, Inc.
GBT
$24.3M 23.36%
356,270
+230,000
+182% +$12.7M
WHWK
4
Whitehawk Therapeutics
WHWK
$190M
$18.3M 17.62%
1,294,785
+920,000
+245% +$12.1M
ASMB icon
5
Assembly Biosciences
ASMB
$498M
$3.65M 3.52%
185,625
RNTX
6
Rein Therapeutics
RNTX
$63.1M
$3.43M 3.31%
830,472
AKBA icon
7
Akebia Therapeutics
AKBA
$354M
$1.47M 1.42%
4,652,561

Similar funds

Alerce Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, Alerce Investment Management held 7 positions worth $104M, up 93% from $53.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Alerce Investment Management deployed $41.5M of net new capital in Q3 2022, adding to 4 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Alerce Investment Management added most to Annexon in Q3 2022, an estimated $13.3M increase.
  • Alerce Investment Management's ten largest holdings make up 100% of its $104M portfolio in Q3 2022.
  • Alerce Investment Management opened 0 new positions and closed 0 in Q3 2022.
  • Alerce Investment Management's portfolio value rose 93% quarter-over-quarter to $104M.

Based on Alerce Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.